Title: Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry.
Authors: Haidry, R J; Butt, M A; Dunn, J M; Gupta, A; Lipman, G; Smart, H L; Bhandari, P; Smith, L; Willert, R; Fullarton, G; Di Pietro, M; Gordon, C; Penman, I; Barr, H; Patel, P; Kapoor, N; Hoare, J; Narayanasamy, R; Ang, Y; Veitch, A; Ragunath, K; Novelli, M; Lovat, L B
Abstract: Barrett's oesophagus (BE) is a pre-malignant condition leading to oesophageal adenocarcinoma (OAC). Treatment of neoplasia at an early stage is desirable. Combined endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) is an alternative to surgery for patients with BE-related neoplasia.
↧